Matches in SemOpenAlex for { <https://semopenalex.org/work/W2509746779> ?p ?o ?g. }
- W2509746779 endingPage "344" @default.
- W2509746779 startingPage "333" @default.
- W2509746779 abstract "Triptolide is a most important active ingredient extracted from traditional Chinese medicine Tripterygium, which has been widely used to treat glomerulonephritis as well as immune-mediated disorders, likely for its immunosuppressive, anti-proliferative and anti-inflammatory effects. In this study, we have investigated the potential protective effects of triptolide against diabetic cardiomyopathy (DCM) by regulating immune system, attenuating inflammatory response, thus resulting in decreased cardiac fibrosis and improved left ventricle function. Sprague-Dawley rats were randomly divided into 5 groups: normal group, diabetic group and diabetic rats treated with triptolide (50, 100, or 200 μg/kg/day resp) for 8 weeks. Cardiac function was performed by echocardiography and histopathology of the hearts was examined with HE, Masson staining and scanning electron microscopy. Immune regulation mediator, macrophage infiltration, inflammatory response and cardiac fibrosis related cytokines were measured by RT-PCR, Western blot and Immunohistochemistry staining. In the diabetic group, the expressions of TLR4 and NF-κB p65 were both up-regulated, which was associated with increased pro-inflammatory cytokines, coupled with cardiac fibrosis and impaired left ventricular function. Interestingly, pathological structure and function of left ventricle were both significantly improved in the triptolide treated groups. Furthermore, the immune mediator TLR4, downstream activator NF-κB p65, macrophage infiltration (CD68+), pro-inflammatory cytokines (TNF-α, IL-1β), cell adhesion molecule (VCAM-1) and chemokine (MCP-1) were significantly suppressed when treated with medium and high dosage triptolide compared with the diabetic group. Moreover, cardiac fibrosis pathway including α-SMA, TGF-β1, vimentin and collagen accumulations were observed significantly decreased in the triptolide treated groups. Our data demonstrated that the protective effects of triptolide against DCM might attribute to inhibition of TLR4-induced NF-κB/IL-1β immune pathway, suppression of NF-κB/TNF-α/VCAM-1 inflammatory pathway and down-regulation of TGF-β1/α-SMA/Vimentin fibrosis pathway." @default.
- W2509746779 created "2016-09-16" @default.
- W2509746779 creator A5009058483 @default.
- W2509746779 creator A5012331857 @default.
- W2509746779 creator A5032427631 @default.
- W2509746779 creator A5044920909 @default.
- W2509746779 creator A5051936772 @default.
- W2509746779 creator A5055299862 @default.
- W2509746779 creator A5056982659 @default.
- W2509746779 creator A5071607713 @default.
- W2509746779 creator A5076807614 @default.
- W2509746779 creator A5078026673 @default.
- W2509746779 creator A5087812404 @default.
- W2509746779 date "2016-12-01" @default.
- W2509746779 modified "2023-10-11" @default.
- W2509746779 title "Protective effects of triptolide on TLR4 mediated autoimmune and inflammatory response induced myocardial fibrosis in diabetic cardiomyopathy" @default.
- W2509746779 cites W1527033426 @default.
- W2509746779 cites W1979013098 @default.
- W2509746779 cites W1979904436 @default.
- W2509746779 cites W1982657650 @default.
- W2509746779 cites W1989101440 @default.
- W2509746779 cites W1994300729 @default.
- W2509746779 cites W1996854381 @default.
- W2509746779 cites W1999330035 @default.
- W2509746779 cites W2010242599 @default.
- W2509746779 cites W2010572052 @default.
- W2509746779 cites W2011211981 @default.
- W2509746779 cites W2012937324 @default.
- W2509746779 cites W2022423369 @default.
- W2509746779 cites W2025004005 @default.
- W2509746779 cites W2028097684 @default.
- W2509746779 cites W2033052999 @default.
- W2509746779 cites W2034657761 @default.
- W2509746779 cites W2035619549 @default.
- W2509746779 cites W2035717904 @default.
- W2509746779 cites W2036272929 @default.
- W2509746779 cites W2039601697 @default.
- W2509746779 cites W2040383667 @default.
- W2509746779 cites W2051129372 @default.
- W2509746779 cites W2054005523 @default.
- W2509746779 cites W2063103866 @default.
- W2509746779 cites W2070647639 @default.
- W2509746779 cites W2081202575 @default.
- W2509746779 cites W2104009986 @default.
- W2509746779 cites W2104483699 @default.
- W2509746779 cites W2109491705 @default.
- W2509746779 cites W2116369874 @default.
- W2509746779 cites W2117213923 @default.
- W2509746779 cites W2117886522 @default.
- W2509746779 cites W2132970411 @default.
- W2509746779 cites W2133065290 @default.
- W2509746779 cites W2133337731 @default.
- W2509746779 cites W2136487005 @default.
- W2509746779 cites W2145437385 @default.
- W2509746779 cites W2145655023 @default.
- W2509746779 cites W2150367899 @default.
- W2509746779 cites W2155734075 @default.
- W2509746779 cites W2156414024 @default.
- W2509746779 cites W2156510924 @default.
- W2509746779 cites W2161918376 @default.
- W2509746779 cites W2171820373 @default.
- W2509746779 cites W2411826498 @default.
- W2509746779 cites W4296981756 @default.
- W2509746779 doi "https://doi.org/10.1016/j.jep.2016.08.029" @default.
- W2509746779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27558948" @default.
- W2509746779 hasPublicationYear "2016" @default.
- W2509746779 type Work @default.
- W2509746779 sameAs 2509746779 @default.
- W2509746779 citedByCount "53" @default.
- W2509746779 countsByYear W25097467792017 @default.
- W2509746779 countsByYear W25097467792018 @default.
- W2509746779 countsByYear W25097467792019 @default.
- W2509746779 countsByYear W25097467792020 @default.
- W2509746779 countsByYear W25097467792021 @default.
- W2509746779 countsByYear W25097467792022 @default.
- W2509746779 countsByYear W25097467792023 @default.
- W2509746779 crossrefType "journal-article" @default.
- W2509746779 hasAuthorship W2509746779A5009058483 @default.
- W2509746779 hasAuthorship W2509746779A5012331857 @default.
- W2509746779 hasAuthorship W2509746779A5032427631 @default.
- W2509746779 hasAuthorship W2509746779A5044920909 @default.
- W2509746779 hasAuthorship W2509746779A5051936772 @default.
- W2509746779 hasAuthorship W2509746779A5055299862 @default.
- W2509746779 hasAuthorship W2509746779A5056982659 @default.
- W2509746779 hasAuthorship W2509746779A5071607713 @default.
- W2509746779 hasAuthorship W2509746779A5076807614 @default.
- W2509746779 hasAuthorship W2509746779A5078026673 @default.
- W2509746779 hasAuthorship W2509746779A5087812404 @default.
- W2509746779 hasConcept C111566952 @default.
- W2509746779 hasConcept C126322002 @default.
- W2509746779 hasConcept C13373296 @default.
- W2509746779 hasConcept C134018914 @default.
- W2509746779 hasConcept C164027704 @default.
- W2509746779 hasConcept C185592680 @default.
- W2509746779 hasConcept C190283241 @default.
- W2509746779 hasConcept C203014093 @default.
- W2509746779 hasConcept C2776553924 @default.
- W2509746779 hasConcept C2776914184 @default.